Borui Pharmaceuticals: Plans to increase capital by 30 million yuan in its equity affiliate, Laitekang

2026-03-12 22:38:41

Borui Pharmaceuticals announced on March 10th that the company plans to increase its capital in its equity affiliate, Light康 (Suzhou) Biopharmaceutical Co., Ltd., by 30 million yuan, of which 461,200 yuan will be registered as capital and the remaining amount will be recorded as capital reserve. After this capital increase, the company’s shareholding will rise from 11.51% to 16.52%. This transaction constitutes a related-party transaction and has been approved by the 18th meeting of the company’s 4th Board of Directors, and does not require shareholder approval.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.